McSweeney, P. A., Nash, R. A., Sullivan, K. M., Crofford, L. J., McDonagh, K. T., Dansey, R., … Furst, D. E. (2001). High-dose immunosuppressive therapy (HDIT) for severe systemic sclerosis (SSc). BLOOD, 98(11), 395B-395B.

McSweeney, P. A., R. A. Nash, K. M. Sullivan, L. J. Crofford, K. T. McDonagh, R. Dansey, M. Mayes, et al. “High-dose immunosuppressive therapy (HDIT) for severe systemic sclerosis (SSc).” BLOOD 98, no. 11 (November 16, 2001): 395B-395B.

McSweeney PA, Nash RA, Sullivan KM, Crofford LJ, McDonagh KT, Dansey R, et al. High-dose immunosuppressive therapy (HDIT) for severe systemic sclerosis (SSc). BLOOD. 2001 Nov 16;98(11):395B-395B.

McSweeney, P. A., et al. “High-dose immunosuppressive therapy (HDIT) for severe systemic sclerosis (SSc).” BLOOD, vol. 98, no. 11, AMER SOC HEMATOLOGY, Nov. 2001, pp. 395B-395B.

McSweeney PA, Nash RA, Sullivan KM, Crofford LJ, McDonagh KT, Dansey R, Mayes M, Holmberg LA, Chen CS, Rambharose J, Storek J, Gooley TA, LeMaistre CF, Ryan K, Sunderhaus J, Furst DE. High-dose immunosuppressive therapy (HDIT) for severe systemic sclerosis (SSc). BLOOD. AMER SOC HEMATOLOGY; 2001 Nov 16;98(11):395B-395B.